These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 3111237)

  • 1. Electrophysiologic and antiarrhythmic effects of oral encainide in patients with atrioventricular nodal reentry or nodoventricular reentry.
    Miles WM; Chang MS; Heger JJ; Rinkenberger RL; Zipes DP; Prystowsky EN
    Am Heart J; 1987 Jul; 114(1 Pt 1):26-33. PubMed ID: 3111237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and electrophysiologic effects of encainide for atrioventricular nodal reentrant tachycardia.
    Naccarelli GV; Jackman WM; Akhtar M; Rinkenberger RL; Friday KJ; Dougherty AH; Tchou P; Yeung-Lai-Wah JA
    Am J Cardiol; 1988 Dec; 62(19):31L-36L. PubMed ID: 3144165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic and clinical effects of oral encainide in paroxysmal atrioventricular node reentrant tachycardia.
    Chimienti M; Li Bergolis M; Moizi M; Salerno JA
    J Am Coll Cardiol; 1989 Oct; 14(4):992-8. PubMed ID: 2507613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of adrenergic stimulation by isoproterenol in reversal of effects of encainide in supraventricular tachycardia.
    Akhtar M; Niazi I; Naccarelli GV; Tchou P; Rinkenberger R; Dougherty AH; Jazayeri M
    Am J Cardiol; 1988 Dec; 62(19):45L-49L. PubMed ID: 3144167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
    Abdollah H; Brugada P; Green M; Wehr M; Wellens HJ
    Am J Cardiol; 1984 Sep; 54(6):544-9. PubMed ID: 6433688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
    Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M
    Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of atrioventricular node reentrant tachycardia with encainide: reversal of drug effect with isoproterenol.
    Niazi I; Naccarelli G; Dougherty A; Rinkenberger R; Tchou P; Akhtar M
    J Am Coll Cardiol; 1989 Mar; 13(4):904-10. PubMed ID: 2494243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of intracardiac recordings to determine the site of drug action in paroxysmal supraventricular tachycardia.
    Jackman WM; Friday KJ; Fitzgerald DM; Yeung-Lai-Wah JA; Lazzara R
    Am J Cardiol; 1988 Dec; 62(19):8L-19L. PubMed ID: 3059792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encainide for treatment of atrioventricular reciprocating tachycardia in the Wolff-Parkinson-White syndrome.
    Miles WM; Zipes DP; Rinkenberger RL; Markel ML; Prystowsky EN; Dougherty AH; Heger JJ; Naccarelli GV
    Am J Cardiol; 1988 Dec; 62(19):20L-25L. PubMed ID: 3144163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ablation of atrioventricular nodal "slow pathway" for simultaneous treatment of coexisting atrioventricular and nodal reciprocating tachycardias.
    Di Biase L; Bai R; Tritto M; Grimaldi M; Biasco MG
    J Interv Card Electrophysiol; 2007 Aug; 19(2):143-7. PubMed ID: 17668304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-arrhythmia and electrophysiological effects of encainide in supraventricular tachycardias].
    Cassagneau B; Miquel JP; Puel JP; Mordant B; Kher A; Fauvel JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():113-9. PubMed ID: 3938253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
    Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
    Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electrophysiologic effects of betaxolol on conduction properties of the antegrade and retrograde pathway in patients with typical atrioventricular node reentry tachycardia following intravenous and oral administration].
    Kühlkamp V; Ickrath O; Haasis R; Seipel L
    Z Kardiol; 1988 Aug; 77(8):527-33. PubMed ID: 3176596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrioventricular block in the atypical form of junctional reciprocating tachycardia: evidence supporting the atrioventricular node as the site of reentry.
    Yeh SJ; Yamamoto T; Lin FC; Wu D
    J Am Coll Cardiol; 1990 Feb; 15(2):385-92. PubMed ID: 2299081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome.
    Prystowsky EN; Klein GJ; Rinkenberger RL; Heger JJ; Naccarelli GV; Zipes DP
    Circulation; 1984 Feb; 69(2):278-87. PubMed ID: 6418407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cycle length alternation during supraventricular tachycardia: occurrence and mechanism in a canine model of AV reentrant tachycardia.
    Talajic M; Villemaire C; Papadatos D; Lemery R; Roy D; Nattel S
    Pacing Clin Electrophysiol; 1990 Mar; 13(3):314-25. PubMed ID: 1690404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of adenosine on antegrade and retrograde fast pathway conduction in atrioventricular nodal reentry.
    Lee CS; Lai WT; Wu JC; Sheu SH; Wu SN; Belardinelli L
    Am Heart J; 1997 Nov; 134(5 Pt 1):799-806. PubMed ID: 9398091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiologic effects of isoproterenol in patients with atrioventricular reentrant tachycardia treated with flecainide.
    Helmy I; Scheinman MM; Herre JM; Sharkey H; Griffin JC
    J Am Coll Cardiol; 1990 Dec; 16(7):1649-55. PubMed ID: 2123908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AV nodal reentrant tachycardia using three different AV nodal pathways.
    Kühlkamp V; Haasis R; Seipel L
    Eur Heart J; 1990 Sep; 11(9):857-62. PubMed ID: 2226514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of intravenous isoproterenol in the electrophysiologic induction of atrioventricular node reentrant tachycardia in patients with dual atrioventricular node pathways.
    Huycke EC; Lai WT; Nguyen NX; Keung EC; Sung RJ
    Am J Cardiol; 1989 Nov; 64(18):1131-7. PubMed ID: 2479251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.